Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LAKKE, J. P.W. F.
Right arrow Articles by TEELKEN, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LAKKE, J. P.W. F.
Right arrow Articles by TEELKEN, A. W.
NEUROLOGY 1976;26:489
© 1976 American Academy of Neurology

Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disorders

J. P.W. F. LAKKE, M.D. and A. W. TEELKEN, Ph.D.

From the Department of Neurology, University Hospital, Groningen, The Netherlands.

Free amino acid determinations in the cerebrospinal fluid of patients with Parkinson's disease or other extrapyramidal disorders showed that in both groups most amino acids were increased. Significantly increased amino acids were neutral and basic amino acids. Amino acid clusters were present and corresponded with the grouping of amino acids in accordance with amino acid transport Systems. The amino acids within the clusters showed a remarkable degree of correlation, and there was a notable correlation between the clusters both in the parkinsonian group and in the group of extrapyramidal disorders, but not in a control group. Our data suggest that in a number of extrapyramidal disorders, Parkinson's disease included, amore generalized abnormality exists than neuronal loss only and, in addition, that patients with these neurologic conditions have a common biochemical defect in their amino acid transport Systems.

Part of this work was presented at the meeting of the Fulton Society, New York, May 31, 1975.

Received for publication July 9, 1975.

Dr. Lakke's address is Department of Neurology, University Hospital, Groningen, The Netherlands.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
A. Y. Shih, D. A. Johnson, G. Wong, A. D. Kraft, L. Jiang, H. Erb, J. A. Johnson, and T. H. Murphy
Coordinate Regulation of Glutathione Biosynthesis and Release by Nrf2-Expressing Glia Potently Protects Neurons from Oxidative Stress
J. Neurosci., April 15, 2003; 23(8): 3394 - 3406.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Sato, M. Tamba, S. Okuno, K. Sato, K. Keino-Masu, M. Masu, and S. Bannai
Distribution of Cystine/Glutamate Exchange Transporter, System xc-, in the Mouse Brain
J. Neurosci., September 15, 2002; 22(18): 8028 - 8033.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
B. V. Manyam, T. N. Ferraro, and T. A. Hare
Cerebrospinal Fluid Amino Compounds in Parkinson's Disease: Alterations due to Carbidopa/Levodopa
Arch Neurol, January 1, 1988; 45(1): 48 - 50.
[Abstract] [PDF]


Home page
Arch NeurolHome page
N. V. B. Manyam, L. Katz, T. A. Hare, J. C. Gerber III, and M. H. Grossman
Levels of {gamma}-Aminobutyric Acid in Cerebrospinal Fluid in Various Neurologic Disorders
Arch Neurol, June 1, 1980; 37(6): 352 - 355.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by AAN Enterprises, Inc.